Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Inter Pharma

Market Cap 2.69B 81.69M 71.48M 65.97M 61.57M 116M 7.72B 117M 785M 305M 3.8B 306M 300M 13.35B P/E 2024
52.3x
P/E 2025 22.8x
Enterprise Value 2.81B 85.32M 74.65M 68.9M 64.31M 121M 8.07B 122M 820M 318M 3.96B 320M 313M 13.94B EV / Sales 2024
1.13x
EV / Sales 2025 1.31x
Free-Float
-
Yield 2024 *
-
Yield 2025 1.59%
11/05 Inter Pharma Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
02/03 Inter Pharma Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2025 CI
02/03 Inter Pharma Public Company Limited announces Annual dividend, payable on May 25, 2026 CI
12/11 Inter Pharma Public Company Limited (SET:IP) agreed to acquire an additional 49% stake in Interpharma- ZEAvita Company Limited from Thai Union Ingredients. CI
12/11 Inter Pharma Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
14/08/25 Inter Pharma Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
13/05/25 Inter Pharma Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
16/04/25 Zhaoke Ophthalmology, Interpharma Strike Thailand Drug Distribution Deal MT
16/04/25 Zhaoke Ophthalmology Limited Enters into Three Distribution and Supply Agreements with Interpharma Public Company Limited CI
01/04/25 Inter Pharma Public Company Limited Signs Exclusive Distribution Agreement with Zhaoke Ophthalmology Company Limited for Comprehensive Eye Care Innovation CI
26/02/25 Inter Pharma Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2024 CI
26/02/25 Inter Pharma Public Company Limited Proposes to Omit Dividend Payment for the Year Ended December 31, 2024 CI
14/11/24 Inter Pharma Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 CI
1 day+1.37%
1 week-0.45%
Current month+3.74%
1 month+7.25%
3 months+6.73%
6 months-3.48%
Current year-3.48%
1 week 4.38
Extreme 4.38
4.56
1 month 4.14
Extreme 4.14
4.56
Current year 3.68
Extreme 3.68
4.62
1 year 2.98
Extreme 2.98
4.7
3 years 2.02
Extreme 2.02
7.88
5 years 2.02
Extreme 2.02
14.95
10 years 1.62
Extreme 1.6176
15.14
Manager TitleAgeSince
Chief Executive Officer 56 01/02/2014
Director of Finance/CFO 56 23/06/2023
Compliance Officer 54 -
Director TitleAgeSince
Director/Board Member 56 08/02/2021
Chairman 72 17/12/2019
Director/Board Member 51 14/06/2017
Date Insider Type Main position Quantity % Market Cap.
21/05Buy

Chief Executive Officer

60,000 0.0099%
21/05Buy

Chief Executive Officer

60,000 0.0099%
20/05Buy

Chief Executive Officer

22,600 0.0037%
Change 5-day change 1-year change 3-year change Capi.($)
+1.37%-0.45%+43.23%-40.37% 80.52M
+0.32%-2.73%+44.49%+143.28% 980B
+1.27%-3.98%+54.41%+41.13% 550B
+6.25%+1.00%+24.13%+68.06% 382B
+0.25%-3.09%+23.33%+16.78% 316B
+0.42%-1.28%+27.89%+14.71% 272B
+1.67%-1.47%+26.76%+32.88% 268B
+2.39%+4.42%-36.96%-45.12% 199B
+2.11%-2.95%+19.14%+51.83% 182B
+0.90%-0.57%+15.09%+60.89% 154B
Average +0.90%-2.29%+24.15%+34.41% 330.24B
Weighted average by Cap. +0.49%-3.50%+31.28%+65.69%

Financials

2024 2025
Net sales 1.91B 58.11M 50.85M 46.93M 43.8M 82.21M 5.49B 82.92M 559M 217M 2.7B 218M 213M 9.49B 2.21B 67.3M 58.88M 54.35M 50.72M 95.2M 6.36B 96.03M 647M 251M 3.13B 252M 247M 10.99B
Net income 37.28M 1.13M 991K 915K 854K 1.6M 107M 1.62M 10.89M 4.23M 52.65M 4.25M 4.16M 185M 122M 3.72M 3.25M 3M 2.8M 5.26M 352M 5.31M 35.75M 13.87M 173M 13.95M 13.65M 608M
Net Debt 209M 6.35M 5.56M 5.13M 4.79M 8.98M 600M 9.06M 61.04M 23.68M 295M 23.81M 23.29M 1.04B 119M 3.63M 3.17M 2.93M 2.73M 5.13M 343M 5.17M 34.85M 13.52M 168M 13.6M 13.3M 592M
Logo Inter Pharma
Interpharma Public Company Limited is a Thailand-based company that develops, researches and distributes healthcare products and beauty initiatives for human beings, and healthcare products for animals. The Company provides wellness and anti-aging products, aesthetic innovation products, companion animal health products and livestock products. Its products include PREBO, YUUU toothpaste, multivitamin, Probac 7, Probac 10, Beta Glucan Plus, Pure Krill Oil, Astacurmin, YUUU cleansing mousse, Perfectha Complement, Perfectha Derm, Perfectha Deep, Perfectha Subskin and Uderma.
Employees
-
Date Price Change Volume
22/06/26 4.440 ฿ +1.37% 211,824
19/06/26 4.380 ฿ -0.90% 256,236
18/06/26 4.420 ฿ -2.64% 324,235
17/06/26 4.540 ฿ +3.65% 269,197
16/06/26 4.380 ฿ -1.79% 100,312

Annual profits - Rate of surprise

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!